Back To Top

02.10.2012

Hepatocellular carcinoma (HCC)
ESMO Congress 2012 - Patient Cases
02.10.2012, 08:00 - 09:00, Hall H
Chair(s):
Presentations: 3
Practice-based questions for multimodality management of stage III NSCLC
ESMO Congress 2012 - Patient Cases
02.10.2012, 08:00 - 09:00, Hall L-M
Chair(s):
Presentations: 4
Prevention and treatment of skin toxicity
ESMO Congress 2012 - Patient Cases
02.10.2012, 08:00 - 09:00, Hall G
Chair(s):
Presentations: 3
The best of the ESMO 2012 Congress
ESMO Congress 2012 - Congress highlights
02.10.2012, 09:00 - 13:00, Hall A
Chair(s):
Presentations: 22

01.10.2012

A paradigm shift in early drug development: Individualizing to more patient benefit
ESMO Congress 2012 - Special Symposium
01.10.2012, 11:00 - 12:30, Hall C
Chair(s):
Presentations: 6
A patient with EGFR mutation who progresses to reversible EGFR TKI: What should we do?
ESMO Congress 2012 - Patient Cases
01.10.2012, 08:00 - 09:00, Hall B
Chair(s):
Presentations: 3
Basic Science and Translational Research II
ESMO Congress 2012 - Poster Discussion session
01.10.2012, 13:00 - 14:00, Hall G
Chair(s):
Presentations: 8
Biologically based treatment in head and neck squamous cell carcinoma
ESMO Congress 2012 - Special Symposium
01.10.2012, 16:00 - 17:30, Hall F2
Chair(s):
Presentations: 7
Breast cancer, locally advanced and metastatic
ESMO Congress 2012 - Poster Discussion session
01.10.2012, 12:45 - 13:45, Hall B
Chair(s):
Presentations: 12
Breast cancer, metastatic
ESMO Congress 2012 - Proffered Paper session
01.10.2012, 13:55 - 15:55, Hall A
Chair(s):
Presentations: 8
Can neo-adjuvant breast cancer data be used to accelerate drug approval?
ESMO Congress 2012 - Controversy session
01.10.2012, 09:30 - 10:30, Hall E
Chair(s):
Presentations: 4
Clinical practice guidelines in rare solid cancers: A comparison across the two sides of the Atlantic
ESMO Congress 2012 - Special Session
01.10.2012, 11:00 - 12:30, Hall F2
Chair(s):
Presentations: 7
CNS tumors
ESMO Congress 2012 - Proffered Paper session
01.10.2012, 16:00 - 17:45, Hall C
Chair(s):
Presentations: 7
Deep DNA sequencing of tumor: ready for prime-time or not?
ESMO Congress 2012 - Controversy session
01.10.2012, 08:00 - 09:00, Hall E
Chair(s):
Presentations: 4
EGFR inhibitors are the best choice for the first line treatment of EGFR mutated lung adenocarcinoma patients
ESMO Congress 2012 - Controversy session
01.10.2012, 15:45 - 16:45, Hall E
Chair(s):
Presentations: 4
Emerging diagnostic and therapeutic targets in gynecological cancers: From science to clinical practice
ESMO Congress 2012 - Special Symposium
01.10.2012, 09:15 - 10:45, Hall B
Chair(s):
Presentations: 6
ERC: Funding opportunities for scientists
ESMO Congress 2012 - Special Session
01.10.2012, 11:00 - 12:30, Hall L-M
Chair(s):
Presentations: 5
ESMO DCTF-AORTIC-SLACOM-UICC-WHO Joint Symposium: Independent and publicly funded research: a new global model
ESMO Congress 2012 - Joint Symposium
01.10.2012, 11:00 - 12:30, Hall G
Chair(s):
Presentations: 8
ESMO-ASCO Joint symposium: Genomics in breast cancer: Opening new doors
ESMO Congress 2012 - Joint Symposium
01.10.2012, 11:00 - 12:30, Hall D
Chair(s):
Presentations: 6
ESMO-ESP Joint Symposium: Molecular diagnostics for personalized cancer treatment
ESMO Congress 2012 - Joint Symposium
01.10.2012, 14:15 - 15:45, Hall C
Chair(s):
Presentations: 6
Give Feedback

© 2016 CTI MEETING TECHNOLOGY. All rights reserved.